323 related articles for article (PubMed ID: 29118230)
21. Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
Lan XW; Zou XB; Xiao Y; Tang J; OuYang PY; Su Z; Xie FY
PLoS One; 2016; 11(8):e0160758. PubMed ID: 27509025
[TBL] [Abstract][Full Text] [Related]
22. Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials.
Lee AW; Tung SY; Ngan RK; Chappell R; Chua DT; Lu TX; Siu L; Tan T; Chan LK; Ng WT; Leung TW; Fu YT; Au GK; Zhao C; O'Sullivan B; Tan EH; Lau WH
Eur J Cancer; 2011 Mar; 47(5):656-66. PubMed ID: 21112774
[TBL] [Abstract][Full Text] [Related]
23. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety.
Wee J; Tan EH; Tai BC; Wong HB; Leong SS; Tan T; Chua ET; Yang E; Lee KM; Fong KW; Tan HS; Lee KS; Loong S; Sethi V; Chua EJ; Machin D
J Clin Oncol; 2005 Sep; 23(27):6730-8. PubMed ID: 16170180
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus and nasopharyngeal cancer.
Verma V; Simone CB; Lin C
Head Neck; 2018 Apr; 40(4):696-706. PubMed ID: 29323765
[TBL] [Abstract][Full Text] [Related]
25. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study.
Guo SS; Tang LQ; Chen QY; Zhang L; Liu LT; Guo L; Mo HY; Luo DH; Huang PY; Xiang YQ; Sun R; Chen MY; Wang L; Lv X; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
Oncotarget; 2016 May; 7(20):29739-48. PubMed ID: 27105538
[TBL] [Abstract][Full Text] [Related]
26. Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma.
Zong J; Xu H; Chen B; Guo Q; Xu Y; Chen C; Weng Y; Zheng W; Pan J; Lin S
Radiat Oncol; 2019 Oct; 14(1):182. PubMed ID: 31640719
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of Concurrent Chemotherapy for Intermediate Risk NPC in the Intensity-Modulated Radiotherapy Era: a Propensity-Matched Analysis.
Zhang F; Zhang Y; Li WF; Liu X; Guo R; Sun Y; Lin AH; Chen L; Ma J
Sci Rep; 2015 Nov; 5():17378. PubMed ID: 26611462
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant chemotherapy in local-regionally advanced nasopharyngeal carcinoma: A National Cancer Database analysis.
Tam M; Lee A; Wu SP; Gerber NK; Li Z; Givi B; Hu K; Schreiber D
Laryngoscope; 2018 Dec; 128(12):2770-2777. PubMed ID: 30133799
[TBL] [Abstract][Full Text] [Related]
29. Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: A Bayesian network meta-analysis.
Yan M; Kumachev A; Siu LL; Chan KK
Eur J Cancer; 2015 Aug; 51(12):1570-9. PubMed ID: 26044925
[TBL] [Abstract][Full Text] [Related]
30. Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment?
Cao X; Han Y; He L; Xiang J; Wen Z
Oral Oncol; 2011 Aug; 47(8):747-52. PubMed ID: 21665523
[TBL] [Abstract][Full Text] [Related]
31. Feasibility and efficacy of chemoradiotherapy for elderly patients with locoregionally advanced nasopharyngeal carcinoma: results from a matched cohort analysis.
Liu H; Chen QY; Guo L; Tang LQ; Mo HY; Zhong ZL; Huang PY; Luo DH; Sun R; Guo X; Cao KJ; Hong MH; Mai HQ
Radiat Oncol; 2013 Mar; 8():70. PubMed ID: 23521779
[TBL] [Abstract][Full Text] [Related]
32. Radiotherapy alone and with concurrent chemotherapy for nasopharyngeal carcinoma: A retrospective study.
Katano A; Takahashi W; Yamashita H; Yamamoto K; Ando M; Yoshida M; Saito Y; Abe O; Nakagawa K
Medicine (Baltimore); 2018 May; 97(18):e0502. PubMed ID: 29718841
[TBL] [Abstract][Full Text] [Related]
33. Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival.
Tian YH; Zou WH; Xiao WW; Zeng L; Yuan X; Bai L; Lu T; Tian Y; Han F
Head Neck; 2016 Aug; 38(8):1152-7. PubMed ID: 27220062
[TBL] [Abstract][Full Text] [Related]
34. Asian Versus Non-Asian Outcomes in Nasopharyngeal Carcinoma: A North American Population-based Analysis.
Hamilton SN; Ho C; Laskin J; Zhai Y; Mak P; Wu J
Am J Clin Oncol; 2016 Dec; 39(6):575-580. PubMed ID: 24879476
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
Ke LR; Xia WX; Qiu WZ; Huang XJ; Yang J; Yu YH; Liang H; Liu GY; Ye YF; Xiang YQ; Guo X; Lv X
BMC Cancer; 2017 Feb; 17(1):134. PubMed ID: 28202000
[TBL] [Abstract][Full Text] [Related]
36. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
[TBL] [Abstract][Full Text] [Related]
37. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
[TBL] [Abstract][Full Text] [Related]
38. Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high-risk extremity/trunk soft-tissue sarcoma?
Chowdhary M; Chowdhary A; Sen N; Zaorsky NG; Patel KR; Wang D
Cancer; 2019 Nov; 125(21):3801-3809. PubMed ID: 31490546
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic Effect of Chemotherapy Cycle in Nasopharyngeal Carcinoma (NPC) Patients Who Developed Bone-Only Metastasis.
Nong S; Pan X; Chen K; Li Y; Zhu X
Med Sci Monit; 2020 Jun; 26():e922244. PubMed ID: 32541642
[TBL] [Abstract][Full Text] [Related]
40. T4/N2 classification nasopharyngeal carcinoma benefit from concurrent chemotherapy in the era of intensity-modulated radiotherapy.
Xie R; Xia B; Zhang X; Hu W; Zhao R; Xie C; Wang J; Zhang N; Wu S
Oncotarget; 2016 Dec; 7(49):81918-81925. PubMed ID: 27636993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]